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Abstract
Background: Plantar heel pain is one of the most common musculoskeletal disorders of the foot
and ankle. Treatment of the condition is usually conservative, however the effectiveness of many
treatments frequently used in clinical practice, including stretching, has not been established. We
performed a participant-blinded randomised trial to assess the effectiveness of calf muscle
stretching, a commonly used short-term treatment for plantar heel pain.
Methods: Ninety-two participants with plantar heel pain were recruited from the general public
between April and June 2005. Participants were randomly allocated to an intervention group that
were prescribed calf muscle stretches and sham ultrasound (n = 46) or a control group who
received sham ultrasound alone (n = 46). The intervention period was two weeks. No participants
were lost to follow-up. Primary outcome measures were 'first-step' pain (measured on a 100 mm
Visual Analogue Scale) and the Foot Health Status Questionnaire domains of foot pain, foot
function and general foot health.
Results: Both treatment groups improved over the two week period of follow-up but there were
no statistically significant differences in improvement between groups for any of the measured
outcomes. For example, the mean improvement for 'first-step' pain (0–100 mm) was -19.8 mm in
the stretching group and -13.2 mm in the control group (adjusted mean difference between groups
-7.9 mm; 95% CI -18.3 to 2.6). For foot function (0–100 scale), the stretching group improved 16.2
points and the control group improved 8.3 points (adjusted mean difference between groups 7.3;
95% CI -0.1 to 14.8). Ten participants in the stretching group experienced an adverse event,
however most events were mild to moderate and short-lived.
Conclusion: When used for the short-term treatment of plantar heel pain, a two-week stretching
program provides no statistically significant benefit in 'first-step' pain, foot pain, foot function or
general foot health compared to not stretching.
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Background
Plantar heel pain (plantar fasciitis) can be a painful and
debilitating condition. It is highly prevalent with one
recent United States study estimating that one million
patient visits each year at office-based physicians and hos-
pital outpatient departments are for the diagnosis and
treatment of plantar heel pain [1]. The disorder appears in
sedentary populations [2-4] with seven percent of adults
aged 65 years or older found to have plantar heel pain
[2,3]. It also makes up one quarter of all foot injuries in
runners [5] and up to 8% of all injuries to people partici-
pating in sporting activities [6-8]. It is the third most com-
mon running injury behind patellofemoral pain and
iliotibial band friction syndrome [9]. The condition is
thought to be multifactorial in origin with factors such as
increased age, decreased ankle and first metatarsophalan-
geal joint range of motion, obesity and excessive periods
of weight-bearing activity commonly suggested to be
involved [10,11].
A wide variety of management strategies have been devel-
oped to treat the disorder. A systematic review [12] iden-
tified 26 different conservative treatments that have been
recommended for the treatment of plantar heel pain. At
the time of the review, only heel pads, orthoses, steroid
injections, night splints and extracorporeal shock wave
therapy had been evaluated in randomised trials. The
review found that although there is limited evidence for
the effectiveness of local corticosteroid therapy, the effec-
tiveness of other frequently employed treatments in alter-
ing the clinical course of plantar heel pain had not been
established.
One of the more common conservative treatments for
plantar heel pain is foot orthoses [13], however due to the
manufacturing process there is often a period of a few
weeks between the initial consultation and issuing the
devices. As such, short-term treatments such as muscle
stretches are regularly used to alleviate symptoms during
this interim period. A recent systematic review [14] of ran-
domised trials examined the effect of calf muscle stretch-
ing on ankle range of motion and found that stretching
produces a small but statistically significant increase in
ankle range of motion. Such an increase may reduce the
symptoms of plantar heel pain by reducing the strain in
the plantar fascia that the calf muscle places on it during
standing and ambulation [15,16]. However, it is unclear
whether a change in ankle range of motion translates to a
clinically relevant outcome for patients.
There have been no randomised controlled trials that have
examined the effectiveness of calf muscle stretching per se.
Two previous randomised controlled trials have com-
pared two active stretching interventions for plantar heel
pain: calf stretching compared with plantar fascia stretch-
ing [17] and sustained calf stretching compared with
intermittent stretching [18]. Neither trial included a sham
or no treatment control group, so the effect of calf muscle
stretching by itself has not been examined. We conducted
a randomised sham-controlled trial to determine whether
calf muscle stretching is an effective short-term treatment
for plantar heel pain.
Methods
A randomised, participant-blinded trial was conducted
between April and June 2005. Participants with a clinical
diagnosis of plantar heel pain and who provided
informed consent were randomly allocated to one of two
groups: (i) an intervention group receiving calf muscle
stretching with sham ultrasound, or (ii) a control group
receiving sham ultrasound only. Participants were
informed prior to entering the study that a sham interven-
tion was being administered in the trial and were blinded
as to whether they received active treatment (i.e. stretch-
ing) or not. Ethical approval for the trial was gained from
the University of Western Sydney Human Research Ethics
Committee.
Participants
Participants were included if diagnosed with plantar heel
pain defined as (i) localised pain at the plantar heel; (ii)
that was worst when first standing or walking after rest;
and (iii) that improved initially after first standing but
worsened with increasing activity. As plantar heel pain is
diagnosed clinically the majority of the time, we chose to
not use expensive imaging procedures for diagnosis; thus
maximising generalisability of our findings to standard
clinical practice. Participants also needed to be 18 years of
age or older and have had symptoms for four weeks or
longer. Patients were excluded from the trial if patient his-
tory revealed any inflammatory, osseous, metabolic or
neurological abnormalities. They were also excluded if
they had received a corticosteroid injection within the
past three months. Participants were encouraged not to
commence use of any new treatments during the trial (e.g.
anti-inflammatory medication, foot orthoses etc.).
Clinical protocol
Participants were recruited from local community news-
paper advertisements in Campbelltown (Sydney, Aus-
tralia) and treated at a university podiatry clinic. The
random allocation sequence was generated using a com-
puter program (Microsoft Excel) in one block (i.e. simple
randomisation). The allocation sequence was concealed
from the researcher (JR) enrolling and assessing partici-
pants in sequentially numbered, opaque, sealed and sta-
pled envelopes. Aluminium foil inside the envelope was
used to render the envelope impermeable to intense light.
To prevent subversion of the allocation sequence, the
name and date of birth of the participant was written onBMC Musculoskeletal Disorders 2007, 8:36 http://www.biomedcentral.com/1471-2474/8/36
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the envelope and a video tape made of the sealed enve-
lope with participant details visible. Carbon paper inside
the envelope transferred the information onto the alloca-
tion card inside the envelope and a second researcher
(CC) later viewed video tapes to ensure envelopes were
still sealed when participants' names were written on
them. Corresponding envelopes were opened only after
the enrolled participants completed all baseline assess-
ments and it was time to allocate the intervention.
Three minutes of sham  ultrasound (Accusonic AS250,
Metron) was then given to the painful heel regardless of
whether participants had been allocated the active inter-
vention (i.e. stretching) or not. The ultrasound unit was
powered with all operational lights activated. At com-
mencement of treatment the researcher (JR) increased the
wattage of the machine which was accompanied by 'beep-
ing' sounds. However, no ultrasound was emitted as the
internal timer was not activated (an external timer was
used instead).
Participants in the stretching group were then given a
wooden stretching wedge (Figure 1) on which to perform
all stretches. This wedge was used to standardise the
stretching technique across participants. The stretching
technique was to be performed while standing. Partici-
pants were instructed to move their forefoot up the wedge
until a stretch could be felt in the calf muscle while keep-
ing their heel on the ground. They were advised to stretch
the muscle for at least 5 minutes a day (a daily journal of
their stretching was kept by all participants). They were
permitted to stretch in smaller sessions (e.g. 1 minute) as
long as a total of at least 5 minutes a day was achieved.
Participants were warned not to overstretch the muscle
and to reduce the force of the stretch by lowering their
foot down the wedge if pain was felt in the calf muscle
while stretching. Advice was given to stretch every day
until the follow-up appointment 14 days later. Partici-
pants were not given any further instruction until the end
of the trial. To assist with blinding, participants exited the
building by a different doorway to the one through which
they entered, thus minimising the likelihood of contact
with other trial participants.
Outcome assessment was performed at baseline and 14
days. Baseline variables that were collected included age,
sex, weight, self-reported hours on feet and duration of
symptoms. Primary outcome measures were 'first-step'
pain – the pain experienced when first standing after aris-
ing from bed in the morning – measured on a 100 mm
Visual Analogue Scale and the Foot Health Status Ques-
tionnaire which has four domains covering foot pain, foot
function, footwear and general foot health (although we
pre-specified that we would not analyse the footwear
domain). The Foot Health Status Questionnaire has been
previously validated (content, criterion and construct
validity) across a wide spectrum of pathologies including
skin, nail and musculoskeletal disorders. It has a high test-
retest reliability (intraclass correlation coefficients ranging
from 0.74 to 0.92) and a high degree of internal consist-
ency (Cronbach's α ranging from 0.85 to 0.88) [19]. Both
measures are self-administered; however to minimise the
investigator having influence on participant responses,
participant-completed outcome assessments were per-
formed prior to each consultation.
Secondary outcome measures were ankle range of motion
and foot posture. Weight-bearing ankle dorsiflexion (a
measure of ankle joint tightness) was measured using the
Lunge Test [20] which is reported to also have high intra-
rater (intraclass correlation coefficient 0.98) and inter-
rater reliability (intraclass correlation coefficient 0.97).
Foot posture (e.g. whether someone has a low- or high-
arched foot) was measured using the Foot Posture Index
(FPI-6) which is reported to have high internal consist-
ency (Cronbach's α 0.83) and high test-retest reliability
(intraclass correlation coefficients ranging from 0.62 to
0.91) [21]. The researcher completing follow-up measure-
ment of ankle dorsiflexion and foot posture was not
blinded to participant allocation.
Sample size, data handling and analysis
The sample size of 92 (i.e. 46 per group), calculated a pri-
ori, was based upon the ability to detect a minimal impor-
tant difference of 10 mm [22-24] on the Visual Analogue
Scale (standard deviation 17) between groups with 80%
probability and alpha level of 0.05. This sample size also
provided adequate power to detect a minimal important
difference between groups of 12 points on the pain
domain of the Foot Health Status Questionnaire (stand-
ard deviation 20). We conservatively ignored the extra
precision provided by the covariate analysis when esti-
mating sample size.
Independent researchers (not otherwise involved in the
trial – see acknowledgments) performed data entry and
were blinded to group allocation. Double data entry was
used to check for errors. Statistical analyses were per-
formed while researchers were blinded to group alloca-
tion.
An independent sample t-test was used to determine if
there was a difference between groups in the number of
days between baseline and follow-up appointments. Out-
come data were analysed by intention to treat and accord-
ing to a pre-planned protocol (i.e. a priori). To maximise
precision of estimates, analysis of covariance (ANCOVA)
was conducted using a linear regression approach [25,26].
The primary outcomes analysed were the change in 'first-
step' pain (Visual Analogue Scale), foot pain, foot func-BMC Musculoskeletal Disorders 2007, 8:36 http://www.biomedcentral.com/1471-2474/8/36
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tion and general foot health (Foot Health Status Ques-
tionnaire). Secondary outcomes included ankle range of
motion (Lunge Test) and foot posture (FPI-6). We pre-
specified that the baseline outcome measure would be used
as the only covariate in each analysis [27] therefore for
each of the primary and secondary outcomes we adjusted
for the outcome at baseline.
Participants were also asked which intervention (active,
sham or don't know) they thought they had received and
an index [28] calculated to assess the success of blinding.
The index takes the value 1 for complete blinding and 0
for complete lack of blinding; 0.5 is the equivalent of ran-
dom guessing.
Results
The flow of participants through the trial is shown in Fig-
ure 2. There were no participants lost to follow-up. Base-
line characteristics (Table 1) of both groups were similar
although the control group had less women 25 (54%) ver-
sus 31 (67%) and were on their feet slightly longer each
day (mean 9.1 SD ± 3.7 hours versus mean 7.5 SD ± 3.5
hours).
Participants in the stretching group stretched for a median
of 14 days (range 5 to 16 days). There was no difference
between the groups in time to follow-up (p = 0.489). The
median time between baseline and the review appoint-
ment was 14 days (range 13 to 16) for the stretching group
and 14 days (range 13 to 15) for the control group.
Both the stretching and control group improved in 'first-
step' pain, foot pain, foot function and general foot health
over the two weeks of follow-up. When compared to the
control group, the stretching group demonstrated a small
improvement in 'first-step' pain (ANCOVA-adjusted
mean difference between groups: -7.9 mm; 95% CI -18.3
to 2.6) and foot function (ANCOVA-adjusted mean differ-
ence between groups: 7.3; 95% CI -0.1 to 14.8) but these
were not statistically significant. Similarly there were no
statistically significant differences between groups for any
of the other primary or secondary outcomes (Tables 2 and
3).
Ten participants (22%) in the stretching group experi-
enced adverse events: increased heel pain while stretching
(n = 4), calf pain (n = 4), and a new pain in lower limb (n
= 2). Adverse events were recorded as mild (n = 4), mod-
erate (n = 2) or severe (n = 4) in nature. One participant
discontinued treatment after 5 days of stretching due to
severe heel pain while stretching. Upon cessation of
stretching, all adverse events resolved. There were no
adverse events reported in the control group.
With respect to blinding, thirty-six participants (78%) in
the stretching group correctly identified their treatment
group compared with twelve participants (26%) in the
control group. Seven participants (15%) in the stretching
group were uncertain which treatment they received, com-
pared with twelve participants (26%) in the control
group. Three participants (7%) in the stretching group
and twenty-two participants (48%) in the control group
incorrectly identified their treatment group. The blinding
index was 0.49 (bootstrap 95% confidence interval 0.39
to 0.57; p < 0.001) interpreted as moderate success of
blinding.
Discussion
The results demonstrate that calf muscle stretching over a
two-week period produces no statistically significant ben-
eficial effects for foot pain and general foot health com-
pared with not stretching. Although there was a trend for
greater improvement in the stretching group in 'first-step'
pain (by approximately 8 points on the 100 point Visual
Analogue Scale) and foot function (by approximately 7
points on the 100 point Foot Health Status Question-
naire) these were also not statistically significant. In
regards to foot function, no minimal important difference
is known for the outcome and therefore the trial may have
been underpowered to detect a statistically significant dif-
ference. Further, no differences were found in secondary
outcomes of ankle range of motion and foot posture.
Stretching wedge Figure 1
Stretching wedge.BMC Musculoskeletal Disorders 2007, 8:36 http://www.biomedcentral.com/1471-2474/8/36
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Participant flow diagram Figure 2
Participant flow diagram.
Participants randomised 
(n=92) 
STRETCHING group 
Calf stretching and 
sham ultrasound 
CONTROL group 
Sham ultrasound only 
Baseline (n=46)  Baseline (n=46) 
Completed treatment (n=46) 
Lost to follow-up (n=0) 
Completed treatment (n=46) 
Lost to follow-up (n=0) 
Assessed for eligibility 
(n=138) 
Excluded (n=46) 
Did not meet inclusion criteria (n=39) 
Refused to participate (n=7) 
Included in analysis (n=46)  Included in analysis (n=46) BMC Musculoskeletal Disorders 2007, 8:36 http://www.biomedcentral.com/1471-2474/8/36
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Participant characteristics in this trial were similar to sam-
ples in previous heel pain trials [13,29-31]. Participants
were primarily middle-aged, overweight and spent the
majority of the day on their feet. Likewise, participants
also presented with relatively chronic symptoms.
The majority of adverse events in this trial were described
by participants as short-lived and mild to moderate in
intensity. Only one participant discontinued stretching
due to an adverse event. Four events were due to increased
pain while stretching, another four were due to calf pain
and two due to a new pain in the lower limb. Participants
noticed that the use of the wooden wedge placed
increased pressure under the heel as the position of the
foot on the wedge during the stretching procedure redis-
tributed force away from the forefoot to the plantar heel
region. This could have led to the four participants report-
ing increased pain while stretching. Caution should there-
fore be used in instructing participants to stretch their calf
muscles by raising their forefoot from the ground (e.g. on
a book or wedge similar to the one used in this trial).
While we chose this form of stretching because it stand-
ardised the stretching technique across participants, alter-
native stretching methods that do not place increased
pressure on the plantar heel (e.g. lowering the heel while
the forefoot is on a step) may avoid such an adverse event.
The findings of this trial need to be viewed in light of
some limitations. Firstly, the evidence from this trial is for
one particular technique of stretching the calf muscle.
Table 1: Baseline characteristics of participants. Values are means (± standard deviation) unless stated otherwise.
Variable Stretching (n = 46) Control (n = 46)
Age in years 50.7 (± 11.8) 50.1 (± 11.0)
BMI in kg/m2 31.6 (± 5.8) 32.1 (± 6.5)
Self reported hours on feet 7.5 (± 3.5) 9.1 (± 3.7)
Period of symptoms in months – median 
(range)
13 (4 to 61) 13 (3 to 121)
No. of women (%) 31 (67.4) 25 (54.3)
Foot affected
Right – No. (%) 15 (32.6) 17 (37.0)
Left – No. (%) 9 (19.6) 13 (28.3)
Both feet – No. (%) 22 (47.8) 16 (34.8)
Table 2: Primary outcomes at baseline and follow-up.
Group
Primary outcome measures Stretching – mean (SD) Control – mean (SD) Adjusted mean difference between 
groups (95% CI)
P-value
'First-step' pain*
Baseline 70.9 (± 23.0) 75.8 (± 19.1)
Follow-up 51.1 (± 29.1) 62.5 (± 29.5)
Mean change -19.8 (± 26.0) -13.2 (± 25.2) -7.9 (-18.3 to 2.6) 0.138
Foot painΨ
Baseline 34.0 (± 21.5) 31.7 (± 17.8)
Follow-up 50.9 (± 23.1) 50.8 (± 26.4)
Mean change 16.9 (± 20.4) 19.2 (± 21.6) -1.6 (-10.1 to 6.9) 0.709
Foot functionΨ
Baseline 56.3 (± 24.5) 58.2 (± 24.0)
Follow-up 72.4 (± 23.6) 66.4 (± 26.2)
Mean change 16.2 (± 19.5) 8.3 (± 18.5) 7.3 (-0.1 to 14.8) 0.052
General foot healthΨ
Baseline 30.8 (± 21.7) 31.5 (± 24.4)
Follow-up 37.3 (± 25.9) 43.3 (± 29.0)
Mean change 6.5 (± 20.8) 11.7 (± 20.7) -5.4 (-13.8 to 3.1) 0.211
* Measured using a Visual Analogue Scale (0 to 100 mm – 0 is no pain and 100 is the worst pain).
Ψ Measured using the Foot Health Status Questionnaire (0 to 100 – 0 is the worst foot health and 100 is the best foot health)
Note: The Foot Health Status Questionnaire is 'reverse-scored' compared to the Visual Analogue Scale. In the results above, the negative adjusted 
mean difference between groups in improvement for the comparison of 'first-step' pain favours stretching because it has lower pain. In comparison, 
a positive score for the Foot Health Status Questionnaire domains favours the stretching groupBMC Musculoskeletal Disorders 2007, 8:36 http://www.biomedcentral.com/1471-2474/8/36
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Although participants reported being able to feel a stretch,
no increase in ankle range of motion was found. Other
stretching techniques such as lunges (dynamic stretch-
ing), proprioceptive neuromuscular facilitation, or using
splints (e.g. night stretching splints) may yield other
results. The stretching technique we utilised – using a
wooden wedge – ensured a suitable stretch was applied in
a relatively controlled manner. Secondly, the trial specifi-
cally examined the effect of stretching over a two-week
period as a short-term treatment for plantar heel pain;
generally the period a patient waits for the fabrication of
a longer-term treatment such as foot orthoses [29]. It
would be of interest to evaluate the effectiveness of regular
stretching over a longer period to investigate whether the
intervention has a long-term effect. This may obviate the
need to institute more expensive long-term treatments
such as foot orthoses; although the risk of a higher inci-
dence of adverse events may not make this worthwhile.
This is the first randomised trial to examine the effect of
calf stretching compared with no stretching for plantar
heel pain. Two previous randomised trials have examined
two different stretching techniques for plantar heel pain
without inclusion of a non-stretching control group
[17,18]. DiGiovanni et al [17] compared calf muscle
stretching with plantar fascia tissue stretches over eight
weeks. Both groups experienced reductions in pain, how-
ever the plantar fascia stretches were found to provide a
statistically significant greater reduction in pain when
compared to the calf muscle stretches. Porter et al [18]
compared sustained 3 minute calf stretches with intermit-
tent 20 second calf stretches for plantar heel pain and
found no significant differences in improvement between
groups. However, without a sham or no stretching control
group, it is not possible to attribute the observed improve-
ments in either trial to the stretching. In view of the
favourable natural history of plantar heel pain partici-
pants in the trial may have improved irrespective of treat-
ment due to the spontaneous resolution of the condition
or as a result of the placebo or Hawthorne effects. Our trial
clearly addresses this limitation and represents a more
precise estimate of the true effect of calf muscle stretches
for plantar heel pain.
Conclusion
When used for the short-term treatment of plantar heel
pain, stretching for two weeks provides no statistically sig-
nificant improvements in 'first-step' pain, foot pain, foot
function and general foot health compared with a control
group. It was also associated with mild to moderate short-
lived adverse events. Based upon our results a program of
calf muscle stretching, similar to that conducted in this
trial, is not recommended for plantar heel pain.
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